药物开发过程:提高效率和成本效益 328条(本栏目收费,不能显示细节,电话13136136841)
Single European Act, 422 422
Single photon emission tomography (SPECT), 248 248
Structure-based drug design (SBDD), 207 207
European Commission (EC), 380 380
European Medicines Evaluation Agency (EMEA), 422 422
European Union (EU), 380 380
clinical pathology studies in, 379-420 420
marketing authorization procedures in, 422-441 441
centralized procedures, 425-431 431
decentralized procedures, 431-436 436
national procedures, 436-437 437
in direct compression, 122-123 123
in drug development, 118-128 128
general characteristics, 119-121 121